Diadexus announces data on lp-pla2 to be presented at international symposium on atherosclerosis diaDexus, Inc., manufacturer of the PLAC Test, announced seven presentations involving Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent predictor for cardiovascular disease, will be presented at the XV International Symposium on Atherosclerosis convening June in Boston, Mass. [more...]